We’re excited to introduce a new company born from our ASCEND2.0 program in Idaho! Spun out of groundbreaking research supported by the Idaho ASCEND2.0 grant, Tozho LLC is developing a novel technology that enables targeted drug delivery—using a specialized carrying unit to transport therapeutics directly to specific locations in the body.

The company, led by John Chavez, Managing Director of NMSUF, works to accelerate the path from research to market through entrepreneurial support and investment. As a collaborator assisting for non-dilutive funding, Dr. Ching-An Peng created the Tozho technology, but he is not part of the company.

“This is exactly the kind of translational science ASCEND2.0 was designed to support,” said John Chavez, managing director of NMSUF. “Tozho represents how regionally rooted research can scale into national impact.”

Learn more about the team and technology here.